Politi, Mary C. http://orcid.org/0000-0001-9103-6495
Forcino, Rachel C.
Parrish, Katelyn
Durand, Marie-Anne
O’Malley, A. James
Elwyn, Glyn
Funding for this research was provided by:
Robert Wood Johnson Foundation (77292)
Article History
Received: 15 November 2020
Accepted: 11 June 2021
First Online: 29 June 2021
Declarations
:
: This study was approved by the Washington University in St. Louis Human Research Protection Office (project # 202004249). The Washington University in St. Louis Human Research Protection Office will review any protocol modifications. We will obtain informed consent from all study participants. Full study results will be published in peer-reviewed outlets, with authorship determined according to International Committee of Medical Journal Editors’ (ICMJE) criteria.
: Not applicable.
: Mary Politi previously (2017-2019) received research funding from Merck & Co on a topic unrelated to this manuscript. Marie-Anne Durand has contributed to the development of the Option Grid patient decision aids, which are licensed to EBSCO Health. Dr. Durand receives consulting income from EBSCO Health, and may receive royalties in the future. Glyn Elwyn is the Founder and Director of &think LLC which owns the registered trademark for Option Grids <sup>TM</sup> patient decision aids; Founder and Director of SHARPNETWORK LLC, a provider of training for shared decision making. Prof. Elwyn provides advice in the domain of shared decision making and patient decision aids to (1) Access Community Health Network, Chicago (Adviser to Federally Qualified Medical Centers), (2) EBSCO Health for Option Grids <sup>TM</sup> patient decision aids (Consultant), (3) Bind On Demand Health Insurance (Consultant), (4) PatientWisdom Inc (Adviser), and (5) abridge AI Inc (Chief Clinical Research Scientist). No other authors declare competing interests.